Severin Schwan: Targeting medicines

Roche is keen to build on its stable of cancer treatments by developing diagnostics that will lead to the creation of more effective medicines. Andrew Jack, pharmaceuticals correspondent, analyses his interview with Severin Schwan, chief executive of the Swiss pharma group, looking at that strategy plus his thoughts on how to make treatments available to the developing world at more affordable prices.